The data shown below were collected from the profiles of 48 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
|
|---|---|
| Published in |
Cochrane database of systematic reviews, April 2010
|
| DOI | 10.1002/14651858.cd002967.pub4 |
| Pubmed ID | |
| Authors |
Shelley R Salpeter, Elizabeth Greyber, Gary A Pasternak, Edwin E Salpeter |
| Abstract |
Metformin is an oral anti-hyperglycemic agent that has been shown to reduce total mortality compared to other anti-hyperglycemic agents, in the treatment of type 2 diabetes mellitus. Metformin, however, is thought to increase the risk of lactic acidosis, and has been considered to be contraindicated in many chronic hypoxemic conditions that may be associated with lactic acidosis, such as cardiovascular, renal, hepatic and pulmonary disease, and advancing age. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 6 | 13% |
| United States | 2 | 4% |
| United Kingdom | 2 | 4% |
| Netherlands | 1 | 2% |
| Brazil | 1 | 2% |
| Colombia | 1 | 2% |
| Sweden | 1 | 2% |
| Unknown | 34 | 71% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 41 | 85% |
| Scientists | 4 | 8% |
| Practitioners (doctors, other healthcare professionals) | 3 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 647 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 4 | <1% |
| Spain | 2 | <1% |
| United States | 2 | <1% |
| Italy | 1 | <1% |
| Hong Kong | 1 | <1% |
| South Africa | 1 | <1% |
| Canada | 1 | <1% |
| Mexico | 1 | <1% |
| Netherlands | 1 | <1% |
| Other | 4 | <1% |
| Unknown | 629 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 84 | 13% |
| Researcher | 77 | 12% |
| Student > Bachelor | 75 | 12% |
| Student > Postgraduate | 64 | 10% |
| Student > Ph. D. Student | 53 | 8% |
| Other | 140 | 22% |
| Unknown | 154 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 308 | 48% |
| Nursing and Health Professions | 35 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 32 | 5% |
| Agricultural and Biological Sciences | 21 | 3% |
| Biochemistry, Genetics and Molecular Biology | 19 | 3% |
| Other | 58 | 9% |
| Unknown | 174 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 64. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 January 2024.
All research outputs
#704,629
of 26,312,176 outputs
Outputs from Cochrane database of systematic reviews
#1,228
of 13,206 outputs
Outputs of similar age
#1,903
of 106,486 outputs
Outputs of similar age from Cochrane database of systematic reviews
#5
of 79 outputs
Altmetric has tracked 26,312,176 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,206 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.6. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 106,486 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 79 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.